Experimental Drug Successfully Suppresses Virus to Undetectable Levels in Clinical Trials
An experimental therapeutic vaccine, known as bepirovirsen, has shown potential in achieving a “functional cure” for chronic hepatitis B, according to results published in the New England Journal of Medicine. Clinical trials indicate that approximately 1 in 5 patients treated with the investigational drug maintained low levels of the hepatitis B virus (HBV) after treatment, … Read more